Serum levels of CA-125, KRT19 and CA19-9 were also significantly increased in early stage PDAC compared to IPMN patients (CA-125 and CA19-9 at p < 0.0001; KRT19 at p < 0.05). The gene discussed is MUC16; the disease is pancreatic intraductal papillary-mucinous neoplasm.